Steward Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Steward Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1K	Buy	+13	New	+$1.4K	﹤0.01%	1309
2023 Q2	–	Sell	-532	Closed	-$58K	–	1101
2023 Q1	$58K	Hold	532	–	–	0.02%	84
2022 Q4	$60K	Buy	+532	New	+$44.2K	0.03%	70
2022 Q3	–	Sell	-524	Closed	-$41K	–	1487
2022 Q2	$41K	Buy	+524	New	+$49.6K	0.03%	109

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Steward Financial Group's HZNP Position: Q3 2023 in Review

Steward Financial Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023: 13 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in HZNP as recently as Q1 2023.

Steward Financial Group first reported a position in HZNP in Q2 2022 and has held it in 4 quarters since. The position peaked at $60K in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Steward Financial Group held 13 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1K as of Q3 2023.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Steward Financial Group position in Q3 2023.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1309 holding.
Steward Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and has held it in 4 quarters since.
Steward Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $60K in Q4 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.